FDA to require new warning of secondary cancer risk for CAR-T cancer therapies |

The Food and Drug Administration (FDA) is requiring a boxed warning on all existing CAR-T cancer treatments following a review of reports that the therapies themselves can increase the risk for som...

Supercharging CAR-T Cells for Cancer Treatment - EPFL

Transformative research at EPFL introduces CAR-T cells that flourish in tumor environments, paving the way for unparalleled advancements in cancer immunotherapy.

Definition of CAR T-cell therapy - NCI Dictionary of Cancer Terms - NCI

About This Website ; Dictionary of Cancer Terms ; Vulnerability Disclosure

CAR T-Cell Study Suggests Promise for Childhood Cancers - NCI

A CAR T-cell therapy targeting the B7-H3 protein may have potential as a treatment for several childhood cancers, results from a study in mice suggest.

Novel CAR T-cell therapy for B-cell cancers shows promise in vivo

A new CAR T-cell therapy for B-cell cancers promises to reduce the antigen escape currently found in therapies that only target CD19.

CAR T cell immunotherapy for human cancer | Science

Related Research Article ; By Nicola Trendel, Philipp Kruger, Stephanie Gaglione, et al. Science Signaling · 19 Jan 2021

CAR T-Cell Therapy: What It Is & How It Works

Chimeric antigen receptor (CAR) T-cell therapy is a blood cancer treatment. Scientists add a gene to T cells that helps the cells detect and kill cancerous cells.

CAR T-Cell Therapy | Chimeric Antigen Receptor Therapy | Rutgers Cancer Institut

CAR T-Cell therapy, a significant breakthrough in cancer treatment, for patients with blood cancers

Rainbow Car | Car show(Cure For Cancer) Penfield,NY | David Schroeder | Flickr - 플리커

Car show(Cure For Cancer) Penfield,NY

CAR-T cell therapy: current limitations and potential strategies | Blood Cancer

Chimeric antigen receptor (CAR)-T cell therapy is a revolutionary new pillar in cancer treatment. Although treatment with CAR-T cells has produced remarkable clinical responses with certain subsets...